Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2026-01-05 @ 6:34 PM
Study NCT ID:
NCT02757950
Status:
COMPLETED
Last Update Posted:
2019-10-01
First Post:
2016-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-14
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-28
First Submit QC Date:
None
Study First Post Date:
2016-05-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-13
Results First Submit QC Date:
None
Results First Post Date:
2019-10-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-04
Last Update Post Date:
2019-10-01
Last Update Post Date Type:
ACTUAL